In vivo efficacy of a bioartificial liver in improving spontaneous recovery from fulminant hepatic failure: A controlled study in pigs

Transplantation

Volumn 69, Issue 3, 2000, Pages 337-344

  Cuervas Mons, Valentín ^a   Coĺas, Antonio ^a   Rivera, Jose A ^a   Prados, Elisa ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL LIVER; CONTROLLED STUDY; FEMALE; INTRACRANIAL PRESSURE; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; SWINE; TREATMENT OUTCOME;

EID: 0343340037     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200002150-00005     Document Type: Article

References (34)

1. Belle HB, Beringer KC, Detre KM. Liver transplantation in the United States: Results from the National Pitt-UNOS liver transplantation registry, p. 19. In: Clinical Transplants, Terasaki PI, Cecka JM, eds., Los Angeles, UCLA Tissue Typing Laboratory 1994.
2. Canadian Organ Replacement Register, 1992 Annual Report, Institute for Health Information, 256. Canadian Institute for Health Information, Toronto, Ontario.
3. European Liver Transplant Registry, December 1997. European Liver Transplant Association, Paris, France.
4. Hoofnagle JH; Carithers RL, Shapiro C, Ascher N. Fulminant hepatic failure. Summary of a workshop. Hepatology 1995; 21: 240.
5. Peleman RR, Gavaler JS, Van Thiel DH, et al. Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology 1987; 7: 484.
6. Emon JC, Aran PP, Whitington PF, Broelsch CE, Baker AL. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 1989; 21: 2435.
7. Anonymous. Trasplante hepatico. Memoria de la Organizacion Nacional de Trasplante, December 1997. Ministerio de Sanidad y Consumo, Madrid, Spain.
8. Nyberg SL, Shirabe K, Peshwa MV, et al. Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions. Cell Transplant 1993; 2: 441.
9. Rozga J, Podesta L, Le Page E, et al. A bioartificial liver to treat severe acute liver failure. Ann Surg 1994; 219: 538.
10. Ellis AJ, Hughes RD, Wendon JA, et al. Pilot-controled trial of the extracorporeal LAD in acute liver failure. Hepatology 1996; 24: 1446
11. Sussman NL, Gislason GT, Conlin CA, Kelly JH. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs 1994; 18: 390.
12. Rozga J, Williams F, Ro MS, et al. Development of a bioartificial liver: properties and function of a hollow fiber module inoculated with liver cells. Hepatology 1993; 17: 258
13. Khalili TM, Navarro A, Ting P, et al. Bioartificial liver treatment prevents development of intracranial hypertension in pigs with fulminant hepatic failure (Abstract). Hepatology 1998; 28: 171A.
14. Watanabe FD, Mullon JP, Hewitt WR, et al. Clinical experience with a bioartificial liver in the treatment of severe liver failure. Ann Surg 1997; 225: 484.
15. Jauregui HO, Mullon CJP, Trenkler D, et al. In vivo evaluation of a hollow fiber liver assist device. Hepatology 21:460.
16. Sielaff TD, Hu MY, Amiot B, et al. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J Surg Res 1995; 59: 179.
17. Sheil AG, Sun J, Mears DC, et al. Preclinical trial of a bioartificial liver support system in a porcine fulminant hepatic failure model. Aust NZ Surg 1996; 66: 547.
18. Chen SC, Hewitt WR, Watanabe FD, et al.Clinical experience with a porcine hepatocyte-based liver support system. Int J Artif Organs 19: 664-669, 1996.
19. Rozga J, Podesta L, LePage E, et al. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 1993; 1: 898.
20. Cuervas-Mons V, Golistin A, Cienfuegos JA, et al. Hepatectomía del 70% y anastomosis porto-cava término-lateral como modelo experimental de insuficiencia aguda fulminante. Rev Esp Enf Ap Digest 1983; 64: 389.
21. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976; 13: 29.
22. Maganto P, Cienfuegos JA, Santamaria L, et al. Cryopreservation and transplantation of hepatocytes: an approach for culture and clinical application. Cryobiology 1988; 25: 311.
23. Vogels BA, Maas MA, Bosma A, Chamuleau RA. Significant improvement of survival by intrasplenic hepatocyte transplantation in totally hepatectomized rats. Cell Transpl 1996; 5: 369
24. Sommer BG, Sutherland DE, Simmons RL, et al. Hepatocellular transplantation for experimental isquemic acute liver failure in dogs. J Surg Res 1980; 29: 310.
25. Takeshita K, Ishibashi H, Szuki M, Kodama M. Hepatocellular transplantation for metabolic support in experimental acute ischemic liver failure in rats. Cell Transplant 1993; 2: 319.
26. Terblanche J; Hickman R, Miller D, et al, Animal experiments with support systems: are there appropiate animal models of fulminant hepatic necrosis? In: Williams R, Murray-Lion I, eds. Artificial liver support. London: Pitman, 1975; 163.
27. Matsumura KN, Guevara R, Huston H, et al. Hybrid bioartificial liver in hepatic failure: preliminary clinical report. Surgery 1987; 101: 99.
28. Demetriou AA, Arnaout WS, Backfisch G, Moscioni AD. Immobilized isolated liver cells on a biomatrix. In Artificial liver support: concepts, methods, results. Bruner G and Mito M, eds. Berlin: Springer-Verlag, 1992; 283-295.
29. Schumaker IK, Okamoto T, Kim BH, Chowdhury NM, Chowdhury JR, Fox IJ. Transplantation of conditionally inmortalized hepatocytes to treat hepatic encephalopathy. Hepatology 1996; 24: 337.
30. Wegmüller A, Montandon A, Nydegger U, Descoedres C. Biocompatibility of different hemodialysis membranes:activation of complement and leucopenia. Int J Artif Organs 1986; 9: 85.
31. Martín-Malo A, Castillo D, Castro M, et al. Biocompatibility of dialysis membranes: a comparative study. Nephrol Dial Transplant 1991; Suppl 2: 55.
32. Barrera P, Janssen EM, Demacker PNM, Wetzels JFM, Van der Meer JWM. Removan of interleukin 1B and tumor necrosis factor from human plasma by in vitro dialysis with polyacrylonitrile membranes. Lymph Cyt Res 1992; 11: 2: 99.
33. Bone RC. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993; 270: 975.
34. Odeh M. Endotoxin and tumor necrosis factor-alfa in the pathogenesis of hepatic encephalopathy. J Clin GE 1994; 19: 146.